Skip Navigation
Skip to contents
Results by Year

View Wide

Filter

ARTICLE TYPE

more+
SELECT FILTER
 
Close

PUBLICATION DATE

130 results
Display

Low-Density Lipoprotein Cholesterol Level, Statin Use and Myocardial Infarction Risk in Young Adults

Jeong H, Han K, Yoo SJ, Kim MK

Objective: The consequences of blood lipid abnormalities for cardiovascular disease risk in young adults is unclear. Optimal lipid levels may also vary depending on whether a statin drug is taken....
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
New, Novel Lipid-Lowering Agents for Reducing Cardiovascular Risk: Beyond Statins

Kim K, Ginsberg HN, Choi SH

Statins are the cornerstone of the prevention and treatment of atherosclerotic cardiovascular disease (ASCVD). However, even under optimal statin therapy, a significant residual ASCVD risk remains. Therefore, there has been...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Statin and aspirin for chemoprevention of hepatocellular carcinoma: Time to use or wait further?

Goh MJ, Sinn DH

Preclinical studies highlighted potential therapeutic applications of aspirin and statins as anticancer agents based on their pleiotropic effects. Epidemiologic studies suggested the role of aspirin and statins in the chemoprevention...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Evidence on Statins, Omega-3, and Prostate Cancer: A Narrative Review

Kim H, Kim JK

Dietary intake selections might play a crucial role in prostate cancer (PCa) occurrence and progression. Several studies have investigated whether statin use could reduce PCa risk but with conflicting results....
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Exploring the Genetic Associations Between the Use of Statins and Alzheimer's Disease

Lee J, Park S, Kim Y, Kim HM, Oh CM

Objective: Alzheimer's disease (AD) is the most common cause of dementia. The statins have shown beneficial effects on cognitive functions and reduced the risk of dementia development. However, the exact...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Impact of Statin Treatment Intensity after Endovascular Revascularization on Lower Extremity Peripheral Artery Disease

Kim GS, Seo J, Kim BG, Jin MN, Lee HY, Kim BO, Byun YS

Purpose: Only a few Asian studies have discussed the impact of statin intensity on clinical outcomes in patients with peripheral artery disease (PAD). We aimed to investigate the clinical impact...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
A Prospective Single-Center Study of Incidence of Atorvastatin-Induced Myalgia in Korean Patients: Application of the Statin Myalgia Clinical Index

Kang K, Kim BK

Background: Statin-induced myalgia is a common cause of discontinuation and a barrier that interferes with long-term treatment. The incidence of myalgia reported by previous atorvastatin trials in Korea ranged from...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
The Association between Medication Use for Dyslipidemia and Osteoporosis

Lee H, Kim J, Rhew K

Background: Osteoporosis is a disease that affects the quality of life and imposes a high socioeconomic burden. Studies have reported that statins, a HMG CoA reductase inhibitor, have a positive...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Statin-Induced Immune-Mediated Necrotizing Myopathy with Anti-HMGCR Antibody

Lee J, Kim E, Kim N, Park HJ, Kim YH

Anti-3-hydroxy-3-methylglutaryl coenzyme A reductase (anti-HMGCR) antibody related immune-mediated necrotizing myopathy (IMNM) are usually associated with statin use. The disease has features of persistent muscle weakness and creatine kinase (CK) elevation...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Statin Supply and Polydrug Use in Older Adults: A Focus on Drug Combinations that Reduce Bone Density

Ho J, Kim B, Kim KS, Jihn CH, Kim MY, Kang DR, Park YH, Ahn J

Background: We investigated the comorbidities of individuals who were prescribed statins to identify the use of bone mineral density (BMD)-reducing drugs, examine polydrug use trends involving these drugs, and explore...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Combination of Simvastatin and FAC Improves Response to Neoadjuvant Chemotherapy in Locally Advanced Breast Cancer

Yulian ED, Siregar NC, B

Purpose The efficacy of neoadjuvant chemotherapy for locally advanced breast cancer (LABC) is limited due to drug resistance and cardiotoxic effects. Preclinical studies have shown that statin induces apoptosis and...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Atherosclerotic Cardiovascular Disease Risk and Statin Prescription Status in Korean Adult Patients

Kim JY, Rhew K

Background: Cardiovascular (CV) disease is known as one of the major causes of death from disease worldwide. Statin therapy plays a pivotal role in atherosclerotic cardiovascular disease (ASCVD) lowering the...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Combination of Statin and Ezetimibe versus Statin Monotherapy on Cardiovascular Disease and Type 2 Diabetes Incidence among Adults with Impaired Fasting Glucose: a PropensityMatched Nationwide Cohort Study

Lee YB, Kim B, Han K, Kim JA, Roh E, Hong Sh, Choi KM, Baik SH, Yoo HJ

Objective: We investigated the effects of statin-ezetimibe combination therapy compared with statin-only treatment on the hazard of incident type 2 diabetes (T2D), myocardial infarction (MI), and stroke among adults with...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Statin Therapy and the Risk of Osteoporotic Fractures in Patients with Metabolic Syndrome: a Nested Case-Control Study

Kim KJ, Choi J, Kim JY, Bae JH, Kim KJ, Kim HY, Yoo HJ, Seo JA, Kim NH, Choi KM, Baik SH, Kim SG, Kim NH

Objective: We aimed to investigate the association between statin use and the risk of major osteoporotic fractures in patients with metabolic syndrome (MetS). Methods: A nested case-control study was performed in...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Bisphosphonate Use Does Not Impact Survival in Patients with Pancreatic Cancer: A Propensity Score Matching Analysis

Zylberberg HM, Rustgi SD, Yang A, Aronson A, Kessel E, Amin S, Lucas AL

Background/Aims: Bisphosphonates are increasingly recognized for their anti-neoplastic properties, which are the result of their action on the mevalonate pathway. Our primary aim was to investigate the association between bisphosphonate...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Effect of pravastatin on erythrocyte membrane fatty acid contents in patients with chronic kidney disease

Lee SM, Son YK, Kim SE, Kim YH, Park Y, An WS

Background: Statin treatment has decreased the risk of cardiovascular events in patients with chronic kidney disease (CKD). Erythrocyte membrane oleic acid level is higher in patients with acute coronary syndrome....
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Comparison of the Effects of Highintensity Statin Therapy with Moderate-Intensity Statin and Ezetimibe Combination Therapy on Major Adverse Cardiovascular Events in Patients with Acute Myocardial Infarction: a Nationwide Cohort Study

Kim K, Bang WD, Han K, Kim B, Lee JM, Chung H

Objective: We compared the effects of high-intensity statin monotherapy versus moderateintensity statin and ezetimibe combination therapy on major adverse cardiovascular events (MACE) in patients with acute myocardial infarction (AMI). Methods: Using...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Effect of Rosuvastatin on Coronary Flow Reserve in Hypertensive Patients at Cardiovascular Risk

Yang Y, Hwang E, Lee SA, Lee S, Kim DH, Song JM, Kang DH

BACKGROUND: It has been unclear whether statin therapy directly improves coronary flow reserve (CFR) in hypertensive patients at cardiovascular risk, independent of lifestyle modification and antihypertensive medications. METHODS: In this double-blind,...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Statin-Naïve Paraneoplastic Anti-HMGCR Myopathy

Yung Y, Kim BY, Oh K, Cho JY

Anti-hydroxy-3-methylglutaryl coenzyme A (HMG-CoA) reductase (anti-HMGCR) myopathy is a subtype of immune-mediated necrotizing myopathy regardless of exposure to statins. Necrotizing myopathy is distinguished by necrotic muscle fibers with a relative...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Atorvastatin Induces FXR and CYP7A1 Activation as a Result of the Sequential Action of PPARγ/PGC-1α/HNF-4α in Hep3B Cells

Lee J, Hong EM, Jung JH, Park SW, Lee SP, Koh DH, Jang HJ, Kae SH

Background/Aims: PPARγ, farnesoid X receptor (FXR) and CYP7A1 are associated with solubility of bile. This study was performed to understand a mechanism and interactions of statin-induced PPARγ, PGC-1α and HNF-4α...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close

Go to Top

Copyright © 2022 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr